Clinical Trial
Accepted on 05 Jul 2024
The optimal dose of dexmedetomidine as a 0.59% ropivacaine adjuvant for epidural anesthesia in great saphenous varicose vein surgery, based on hemodynamics and anesthesia efficacy: A randomized, controlled, double-blind clinical trial
in Intensive Care Medicine and Anesthesiology